Summary of HIV/AIDS
Summary of HIV/AIDS
Summary of HIV/AIDS
Scribe: Salsabeel M
1. Structure
Function
Gag
Group-specific antigens
p24
p7p9
p17
pol
Reverse transcriptase
integrase
protease
Env
Gp120
Gp41
REGULATORY GENES
Structural proteins
Capsid protein
Core nucleocapsid protein
Matrix protein
Produces dsDNA provirus
Viral DNA integration into host cell DNA
Cleaves viral protein
Surface protein that binds to CD4 and coreceptors
Transmembrane protein for viral fusion to host cell
LTR
Tat
Rev
Nef
Regulatory proteins
2. Mode of transmission
i.
ii.
iii.
iv.
v.
Sexual transmission
Perinatal transmission
Intravenous drug use
Blood transfusion
Occupational exposure
1
U2P8G2 2
Scribe: Salsabeel M
Receptors
CD4 for T cells and DC
Lectin and proteoglycans for
DC
Lipid receptor for genital and
intestinal epithelial cells
Coreceptors
CXCR4 on T cells
CCR5 on epithelial cells,
macrophage, DC and T cells
U2P8G2 3
Scribe: Salsabeel M
Eclipse phase (approx. 10days following infection) : T cells and DC affected at the
site of infection
ii.
End of eclipse phase: virus to draining lymph nodes meet activated CD4+ and
CCR5+ T cells (targets for further infection) virus replicate rapidly spread to
GALT where activated T cells are present in high numbers recruitment of
additional T cells to site.
In GALT, 20% T cells infected and 60% uninfected T cells are activated and die
by apoptosis release of microparticles suppress immune system
Time between infection and onset of clinically apparent disease= approx. 10yrs
Skin rash, fatigue, slight weight loss, mouth ulcers, fungal skin and nail infection
Hairy leukoplakia
Chronic oral and vaginal thrush, recurrent herpes blisters on mouth or genitals,
ongoing fever, persistent diarrhoea, significant weight loss
An AIDS diagnosis can be given to an HIV positive person who has a CD4 count
of less than 200/mm3 or a history of an AIDS defining illness( such as one of the
opportunistic infection mentioned above).
U2P8G2 4
Scribe: Salsabeel M
6. HIV latency
7. Immune Response
A. Innate Immunity
1. TLR : PAMPS generated by HIV infection are recognised by TLR leading to
expression of antiviral and inflammatory gene products
2. DCs: HIV does not induce maturation of DCs leading to bystander DCs.
3. NK cells: decreased intracellular stores of perforin and granzyme A and
incomplete activation of NK cells due to chronic stimulation.
4. Macrophages : escape killing and act as reservoir for viral replication
B. Adaptive Immunity
1. B cells responses
HIV induced B cell hyperactivity leading to hypergammaglobulinemia,
increased polyclonal B cell activation, increased differentiation into
plasmablasts, increase production of autoantibodies, increase frequency
of B cell malignancies (e.g Non-Hodgins lymphoma)
B cell exhaustion leading to increased level of inhibitory receptors such
as programmed cell death
2. Cytotoxic CD8+ T cell- control HIV replication
3. Inactivation of Helper CD4+ T cells
U2P8G2 5
Scribe: Salsabeel M
Test
Rapid test
confirmation
Western blot
RT-PCR
PCR
p24 antigen
NOTE: RT-PCR tests for circulating viral RNA and is used to monitor the efficacy of treatment while
PCR detects integrated virus (provirus). Viral load has been demonstrated to be the best prognostic
indicator during infection.
9. Treatment
Antiretroviral drugs against HIV-(start at CD4 < 500)
1. Reverse transcriptase inhibitor
i.
ii.
iii.
HAART: 2NRTIs
inhibitor
Advantages:
i.
ii.
iii.
Higher efficacy
and low side
effects profile